1. New Zealand Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited

FSPKF
Fisher & Paykel Healthcare Corporation LimitedUS flagOther OTC
20.55
USD
- -
- -
12.07BMarket Cap
Fisher & Paykel Healthcare Corporation Limited
FSPKF
(Other OTC)

Recent

price

20.55

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
0.9
0.89
0.94
1.04
1.16
1.46
1.54
1.69
1.87
2.22
3.38
2.85
2.75
3.02
2.19
3.93
Revenue per Share
0.1
0.12
0.14
0.18
0.2
0.26
0.3
0.33
0.37
0.5
0.91
0.65
0.43
0.23
0.64
0.8
Basic EPS, GAAP
0.02
0.01
0.01
0.12
0.16
0.11
0.2
-0.17
-0.23
-0.3
-0.32
-0.29
-0.37
-0.58
-0.18
-0.33
Free Cash Flow per Basic Share
0.13
0.13
0.13
0.13
0.09
0.12
0.16
0.18
0.2
0.25
0.31
0.39
0.34
0.25
0.33
0.43
Dividend per Share
0.43
0.47
0.53
0.63
0.74
0.88
1.01
1.17
1.34
1.59
2.22
2.5
2.6
2.58
2.9
3.3
Book Value per Share
0.6
0.65
0.68
0.72
0.81
0.9
1.09
1.25
1.49
1.57
2.5
2.76
2.88
2.87
3.09
3.48
Tangible Book Value per Share
517
526
538
547
556
561
566
570
573
574
576
577
578
582
586
587
Basic Weighted Avg Shares
468
467
507
569
644
818
870
964
1,072
1,273
1,948
1,642
1,589
1,758
1,280
2,308
Sales/Revenue/Turnover
7.71
3.83
6.89
9.68
16.32
21.24
19.68
21.14
23.09
25.76
31.02
22.55
15.15
14.47
-28.98
20.7
Operating Margin (%)
22
23
26
30
32
35
39
45
42
61
85
96
99
114
140
159
Depreciation Expense
52
64
77
97
113
143
169
190
209
287
524
377
250
133
377
468
Net Income, GAAP
43.47
30.55
29.56
28.98
28.72
28.58
29.06
28.98
28.16
22.46
27.01
25.25
23.69
43.74
25.05
25.81
Effective Tax Rate (%)
11.22
13.74
15.19
17.07
17.57
17.52
19.45
19.72
19.51
22.56
26.91
22.95
15.76
7.54
29.46
20.3
Profit Margin (%)
102
44
124
106
126
136
204
246
271
184
492
584
484
320
435
654
Working Capital
82
35
117
64
51
47
40
52
69
44
92
87
124
93
67
113
LT Debt
313
348
372
406
471
542
662
761
913
974
1,521
1,680
1,753
1,759
1,890
2,115
Total Equity
5.08
2.81
5.03
7.57
13.96
21.14
17.84
18.07
18.83
23.45
30.06
15.36
9.87
7.39
-13.61
15.89
Return on Invested Capital (%)
18.05
19.61
20.57
23.45
26.03
29.22
28.89
27.91
26.53
30.52
43.18
25.86
15.98
8.56
21.8
24.23
Return on Capital (%)
24.26
27.24
28.88
30.76
29.88
31.74
31.8
30.71
29.18
34.2
47.87
27.71
16.99
8.83
23.62
25.81
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.45%
6.9%
11.9%
Free Cash Flow
5.78%
19.34%
89.51%
Net Income, GAAP
26.01%
19.99%
24.2%
Sales/Revenue/Turnover
14.49%
8.96%
80.3%
Total Cash Common Dividend
15.8%
9.77%
28.79%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1,758
2025
1,280
- -
- -
- -
1,280
2026
- -
- -
- -
- -
2,308

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.23
2025
0.64
- -
- -
- -
0.64
2026
- -
- -
- -
- -
0.8

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.25
2025
0.33
- -
- -
- -
0.33
2026
- -
- -
- -
- -
0.43
Similar Companies
Bioservo Technologies AB (publ) (BIOS.ST)
Caina Technology Co., Ltd. (301122.SZ)
Sansure Biotech Inc. (688289.SS)
Singular Genomics Systems, Inc. (OMIC)
Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
COLTENE Holding AG (CLHLF)
Business
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets innovative medical devices and systems for acute care, respiratory support and the treatment of obstructive sleep apnea. The company offers hospital products including humidification systems, breathing circuits, chambers, masks, nasal cannulas, surgical accessories and interfaces; homecare products such as noninvasive ventilation systems, Optiflow nasal high flow therapy and obstructive sleep apnea masks including the Nova Nasal OSA mask; and specialized solutions for neonatal, infant and surgical care. Fisher & Paykel Healthcare operates globally with key facilities in New Zealand, the United States, Australia, the United Kingdom and Mexico, serving hospitals, homecare providers and medical device manufacturers primarily in North America (46% of revenue), Europe (27%) and Asia Pacific (21%); it maintains headquarters in East Tamaki, Auckland, New Zealand, where it was established in 1969 as part of Fisher & Paykel Industries and separated as a standalone public company listed on the NZX and ASX in 2001. Recent developments include the opening of a third manufacturing facility in Tijuana, Mexico, to enhance production efficiencies and proximity to North American markets; plans for a new facility in Guangzhou, China; strong revenue growth to NZ$1.74 billion in FY24 with underlying net profit after tax up 6% to NZ$264.4 million driven by hospital consumables and OSA mask demand; FY25 guidance projecting revenue of NZ$1.9 billion to NZ$2 billion and net profit of NZ$320 million to NZ$370 million supported by new product introductions like the Airvo 3 system and gross margin expansion to 61.1% through manufacturing improvements and pricing; and H1 FY26 revenue reaching NZ$1.09 billion with 14.6% year-over-year growth and net profit increasing 39%.

Company News

APIChat

  • seekingalpha.com

    Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2026 Earnings Call Transcript

  • defenseworld.net

    Fisher & Paykel Healthcare (OTCMKTS:FSPKF) Stock Price Down 17.3% – Time to Sell?

  • seekingalpha.com

    Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2026 Earnings Call Transcript

  • seekingalpha.com

    Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2025 Earnings Call Transcript

  • seekingalpha.com

    Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2024 Earnings Call Transcript

  • seekingalpha.com

    Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2024 Earnings Call Transcript